These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22452288)

  • 21. Effect of ICD Therapies on Mortality in the OMNI Trial.
    Sun S; Johnson J; Degroot P; Brown ML; Obel O
    J Cardiovasc Electrophysiol; 2016 Feb; 27(2):192-9. PubMed ID: 26501695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Apical versus Non-Apical Lead: Is ICD Lead Position Important for Successful Defibrillation?
    Amit G; Wang J; Connolly SJ; Glikson M; Hohnloser S; Wright DJ; Brachmann J; Defaye P; Neuzner J; Mabo P; Vanerven L; Vinolas X; O'Hara G; Kautzner J; Appl U; Gadler F; Stein K; Konstantino Y; Healey JS
    J Cardiovasc Electrophysiol; 2016 May; 27(5):581-6. PubMed ID: 26888558
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparison of basic electrical features of ICD defibrillating leads implanted to right ventricular apex or right ventricular outflow track and septum].
    Szafraniec Z; Kaczmarek K; Pałka K; Ptaszyński P; Ruta J; Chudzik M; Wranicz JK
    Pol Merkur Lekarski; 2014 Mar; 36(213):155-9. PubMed ID: 24779211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A stepwise electrocardiographic algorithm for differentiation of mid-septal vs. apical right ventricular lead positioning: the SPICE ECG substudy.
    Andrikopoulos G; Tzeis S; Asbach S; Semmler V; Lennerz C; Solzbach U; Grebmer C; Kloppe A; Klein N; Pastromas S; Biermann J; Kolb C;
    Europace; 2015 Jun; 17(6):915-20. PubMed ID: 25573656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alternate site right ventricular pacing: defining template scoring.
    Mond HG; Feldman A; Kumar S; Rosso R; Hung TT; Pang B
    Pacing Clin Electrophysiol; 2011 Sep; 34(9):1080-6. PubMed ID: 21605136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
    Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
    Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The clinical implications of cumulative right ventricular pacing in the multicenter automatic defibrillator trial II.
    Steinberg JS; Fischer A; Wang P; Schuger C; Daubert J; McNitt S; Andrews M; Brown M; Hall WJ; Zareba W; Moss AJ;
    J Cardiovasc Electrophysiol; 2005 Apr; 16(4):359-65. PubMed ID: 15828875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Parameters of cardiac pacing and effectiveness of defibrillation during implantable cardioverter-defibrillator lead implantation to right ventricle outflow tract].
    Rydlewska A; Machejek J; Engel A; Lelakowski J
    Pol Merkur Lekarski; 2013 Nov; 35(209):254-8. PubMed ID: 24575643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial: rationale, design, results, clinical implications and lessons for future trials.
    Wilkoff BL;
    Card Electrophysiol Rev; 2003 Dec; 7(4):468-72. PubMed ID: 15071277
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of spironolactone on ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators.
    Zarraga IG; Dougherty CM; MacMurdy KS; Raitt MH
    Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):739-47. PubMed ID: 22773022
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Idiopathic ventricular arrhythmia originating from the cardiac crux or inferior septum: epicardial idiopathic ventricular arrhythmia.
    Kawamura M; Gerstenfeld EP; Vedantham V; Rodrigues DM; Burkhardt JD; Kobayashi Y; Hsia HH; Marcus GM; Marchlinski FE; Scheinman MM; Badhwar N
    Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1152-8. PubMed ID: 25225238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular septal and left ventricular apical pacing chronically maintain cardiac contractile coordination, pump function and efficiency.
    Mills RW; Cornelussen RN; Mulligan LJ; Strik M; Rademakers LM; Skadsberg ND; van Hunnik A; Kuiper M; Lampert A; Delhaas T; Prinzen FW
    Circ Arrhythm Electrophysiol; 2009 Oct; 2(5):571-9. PubMed ID: 19843926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Right ventricular septal pacing: a comparative study of outflow tract and mid ventricular sites.
    Rosso R; Medi C; Teh AW; Hung TT; Feldman A; Lee G; Mond HG
    Pacing Clin Electrophysiol; 2010 Oct; 33(10):1169-73. PubMed ID: 20636311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
    Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
    Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in tachyarrhythmia detection and implantable cardioverter defibrillator therapy by primary or secondary prevention indication in cardiac resynchronization therapy patients.
    Wilkoff BL; Hess M; Young J; Abraham WT
    J Cardiovasc Electrophysiol; 2004 Sep; 15(9):1002-9. PubMed ID: 15363071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
    J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Right ventricular septal pacing: the success of stylet-driven active-fixation leads.
    Rosso R; Teh AW; Medi C; Hung TT; Balasubramaniam R; Mond HG
    Pacing Clin Electrophysiol; 2010 Jan; 33(1):49-53. PubMed ID: 19804487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple appropriate and spurious defibrillator shocks in a patient with right ventricular cardiomyopathy.
    Strohmer B; Schernthaner C; Pichler M
    Int J Cardiol; 2005 Jul; 102(2):363-6. PubMed ID: 15982515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Non-invasive evaluation of ventricular refractoriness and its dispersion during ventricular fibrillation in patients with implantable cardioverter defibrillator.
    Luo J; Pripp CM; Hertervig E; Kongstad O; Ljungström E; Olsson SB; Yuan S
    BMC Cardiovasc Disord; 2004 Jun; 4():8. PubMed ID: 15186504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.